{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T00:21:29Z","timestamp":1723076489814},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,8,6]]},"DOI":"10.7759\/cureus.66332","type":"journal-article","created":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T02:52:48Z","timestamp":1722999168000},"source":"Crossref","is-referenced-by-count":0,"title":["Human and Mouse Nephrin and Their Interactions With 13 Proteins: An In Silico Study"],"prefix":"10.7759","author":[{"given":"Radhakrishnan","family":"Narayanaswamy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vemugadda","family":"Harika","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasantha-Srinivasan","family":"Prabhakaran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","article-title":"Nephrin and podocalyxin - new podocyte proteins for early detection of secondary nephropathies","volume":"14","author":"Kostovska I","year":"2016","unstructured":"Kostovska I, Trajkovska KT, Cekovska S, Spasovski G, Labudovic D. Nephrin and podocalyxin - new podocyte proteins for early detection of secondary nephropathies. Bantao. 2016, 14:11-6.","journal-title":"Bantao"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2013.78","article-title":"The role of the podocyte in albumin filtration","volume":"9","author":"Brinkkoetter PT","year":"2013","unstructured":"Brinkkoetter PT, Ising C, Benzing T. The role of the podocyte in albumin filtration. Nat Rev Nephrol. 2013, 9:328-36. 10.1038\/nrneph.2013.78","journal-title":"Nat Rev Nephrol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/path.2661","article-title":"Nephrin-signature molecule of the glomerular podocyte?","volume":"220","author":"Welsh GI","year":"2010","unstructured":"Welsh GI, Saleem MA. Nephrin-signature molecule of the glomerular podocyte?. J Pathol. 2010, 220:328-37. 10.1002\/path.2661","journal-title":"J Pathol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s10157-020-01854-3","article-title":"New insight into podocyte slit diaphragm, a therapeutic target of proteinuria","volume":"24","author":"Kawachi H","year":"2020","unstructured":"Kawachi H, Fukusumi Y. New insight into podocyte slit diaphragm, a therapeutic target of proteinuria. Clin Exp Nephrol. 2020, 24:193-204. 10.1007\/s10157-020-01854-3","journal-title":"Clin Exp Nephrol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.V10112440","article-title":"Unraveling the mechanisms of glomerular ultrafiltration: nephrin, a key component of the slit diaphragm","volume":"10","author":"Tryggvason K","year":"1999","unstructured":"Tryggvason K. Unraveling the mechanisms of glomerular ultrafiltration: nephrin, a key component of the slit diaphragm. J Am Soc Nephrol. 1999, 10:2440-5. 10.1681\/ASN.V10112440","journal-title":"J Am Soc Nephrol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2019.07.048","article-title":"Urinary podocyte-associated mRNA profile in Egyptian patients with diabetic nephropathy","volume":"13","author":"Fayed A","year":"2019","unstructured":"Fayed A, Rahman Tohamy IA, Kahla H, Elsayed NM, El Ansary M, Saadi G. Urinary podocyte-associated mRNA profile in Egyptian patients with diabetic nephropathy. Diabetes Metab Syndr. 2019, 13:2849-54. 10.1016\/j.dsx.2019.07.048","journal-title":"Diabetes Metab Syndr"},{"key":"ref7","doi-asserted-by":"crossref","DOI":"10.21608\/geget.2021.216778","article-title":"Urinary nephrin as a marker of glomerular diseases in pediatric patients","volume":"16","author":"El-Sebai A","year":"2021","unstructured":"El-Sebai A, Yousef M, Shaaban MA, El-Farsy MS. Urinary nephrin as a marker of glomerular diseases in pediatric patients. GEGET. 2021, 16:53-62.","journal-title":"GEGET"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.4103\/ijn.IJN_305_19","article-title":"A study of association of urinary nephrin with albuminuria in patients with diabetic nephropathy","volume":"31","author":"Kondapi K","year":"2021","unstructured":"Kondapi K, Kumar NL, Moorthy S, Silambanan S. A study of association of urinary nephrin with albuminuria in patients with diabetic nephropathy. Indian J Nephrol. 2021, 31:142-8. 10.4103\/ijn.IJN_305_19","journal-title":"Indian J Nephrol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1186\/2050-7771-2-21","article-title":"Nephrin - a biomarker of early glomerular injury","volume":"2","author":"Kandasamy Y","year":"2014","unstructured":"Kandasamy Y, Smith R, Lumbers ER, Rudd D. Nephrin - a biomarker of early glomerular injury. Biomark Res. 2014, 2:21. 10.1186\/2050-7771-2-21","journal-title":"Biomark Res"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2014.67","article-title":"Matrix metalloproteinase-9 deficiency attenuates diabetic nephropathy by modulation of podocyte functions and dedifferentiation","volume":"86","author":"Li SY","year":"2014","unstructured":"Li SY, Huang PH, Yang AH, et al.. Matrix metalloproteinase-9 deficiency attenuates diabetic nephropathy by modulation of podocyte functions and dedifferentiation. Kidney Int. 2014, 86:358-69. 10.1038\/ki.2014.67","journal-title":"Kidney Int"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/FJC.0000000000001473","article-title":"Knockout of matrix metalloproteinase 2 opposes hypertension- and diabetes-induced nephropathy","volume":"82","author":"Hirata T","year":"2023","unstructured":"Hirata T, Fan F, Fan L, et al.. Knockout of matrix metalloproteinase 2 opposes hypertension- and diabetes-induced nephropathy. J Cardiovasc Pharmacol. 2023, 82:445-57. 10.1097\/FJC.0000000000001473","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000018626","article-title":"Urinary fatty acid and retinol binding protein-4 predict CKD progression in severe NAFLD patients with hypertension: 4-year study with clinical and experimental approaches","volume":"99","author":"Tsai YL","year":"2020","unstructured":"Tsai YL, Liu CW, Huang SF, et al.. Urinary fatty acid and retinol binding protein-4 predict CKD progression in severe NAFLD patients with hypertension: 4-year study with clinical and experimental approaches. Medicine (Baltimore). 2020, 99:e18626. 10.1097\/MD.0000000000018626","journal-title":"Medicine (Baltimore)"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-020-05144-1","article-title":"Decreased plasma kallikrein activity is associated with reduced kidney function in individuals with type 1 diabetes","volume":"63","author":"H\u00e4rma MA","year":"2020","unstructured":"H\u00e4rma MA, Dahlstr\u00f6m EH, Sandholm N, Forsblom C, Groop PH, Lehto M. Decreased plasma kallikrein activity is associated with reduced kidney function in individuals with type 1 diabetes. Diabetologia. 2020, 63:1349-54. 10.1007\/s00125-020-05144-1","journal-title":"Diabetologia"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics13193077","article-title":"Unveiling the hidden power of uromodulin: a promising potential biomarker for kidney diseases","volume":"13","author":"Thielemans R","year":"2023","unstructured":"Thielemans R, Speeckaert R, Delrue C, De Bruyne S, Oyaert M, Speeckaert MM. Unveiling the hidden power of uromodulin: a promising potential biomarker for kidney diseases. Diagnostics (Basel). 2023, 13:3077. 10.3390\/diagnostics13193077","journal-title":"Diagnostics (Basel)"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.807119","article-title":"Insulin-like growth factor binding proteins in kidney disease","volume":"12","author":"Wang S","year":"2021","unstructured":"Wang S, Chi K, Wu D, Hong Q. Insulin-like growth factor binding proteins in kidney disease. Front Pharmacol. 2021, 12:807119. 10.3389\/fphar.2021.807119","journal-title":"Front Pharmacol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1080\/14737159.2020.1768849","article-title":"Cystatin C as a biomarker of chronic kidney disease: latest developments","volume":"20","author":"Benoit SW","year":"2020","unstructured":"Benoit SW, Ciccia EA, Devarajan P. Cystatin C as a biomarker of chronic kidney disease: latest developments. Expert Rev Mol Diagn. 2020, 20:1019-26. 10.1080\/14737159.2020.1768849","journal-title":"Expert Rev Mol Diagn"},{"key":"ref17","article-title":"Urinary podocin level as a predictor of diabetic kidney disease","volume":"8","author":"ElShaarawy A","year":"2019","unstructured":"ElShaarawy A, Abdelmoneim BM, Abdelhameed BS, Abdelsattar HA, Shadad E. Urinary podocin level as a predictor of diabetic kidney disease. J Nephropathol. 2019, 8:e26.","journal-title":"J Nephropathol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-017-1606-5","article-title":"\u03b2-Arrestin-1 deficiency ameliorates renal interstitial fibrosis by blocking Wnt1\/\u03b2-catenin signaling in mice","volume":"96","author":"Xu H","year":"2018","unstructured":"Xu H, Li Q, Liu J, et al.. \u03b2-Arrestin-1 deficiency ameliorates renal interstitial fibrosis by blocking Wnt1\/\u03b2-catenin signaling in mice. J Mol Med (Berl). 2018, 96:97-109. 10.1007\/s00109-017-1606-5","journal-title":"J Mol Med (Berl)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2014040340","article-title":"Deficiency of the planar cell polarity protein Vangl2 in podocytes affects glomerular morphogenesis and increases susceptibility to injury","volume":"26","author":"Rocque BL","year":"2015","unstructured":"Rocque BL, Babayeva S, Li J, et al.. Deficiency of the planar cell polarity protein Vangl2 in podocytes affects glomerular morphogenesis and increases susceptibility to injury. J Am Soc Nephrol. 2015, 26:576-86. 10.1681\/ASN.2014040340","journal-title":"J Am Soc Nephrol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1002\/path.5181","article-title":"Increased dynamin expression precedes proteinuria in glomerular disease","volume":"247","author":"Khalil R","year":"2019","unstructured":"Khalil R, Koop K, Kreutz R, Spaink HP, Hogendoorn PC, Bruijn JA, Baelde HJ. Increased dynamin expression precedes proteinuria in glomerular disease. J Pathol. 2019, 247:177-85. 10.1002\/path.5181","journal-title":"J Pathol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-12382-8","article-title":"C1-Ten is a PTPase of nephrin, regulating podocyte hypertrophy through mTORC1 activation","volume":"7","author":"Lee J","year":"2017","unstructured":"Lee J, Koh A, Jeong H, Kim E, Ha TS, Saleem MA, Ryu SH. C1-Ten is a PTPase of nephrin, regulating podocyte hypertrophy through mTORC1 activation. Sci Rep. 2017, 7:12346. 10.1038\/s41598-017-12382-8","journal-title":"Sci Rep"},{"key":"ref22","doi-asserted-by":"crossref","DOI":"10.3390\/pr11061722","article-title":"STITCH, physicochemical, ADMET, and in silico analysis of selected Mikania constituents as anti-inflammatory agents","volume":"11","author":"Radhakrishnan N","year":"2023","unstructured":"Radhakrishnan N, Prabhakaran VS, Wadaan MA, Baabbad A, Vinayagam R, Kang SG. STITCH, physicochemical, ADMET, and in silico analysis of selected Mikania constituents as anti-inflammatory agents. Processes. 2023, 11:1722.","journal-title":"Processes"},{"key":"ref23","article-title":"Identification of anti-inflammatory metabolites from Trigonella foenum-greacum using computational approaches","volume":"2","author":"Maaz M","year":"2022","unstructured":"Maaz M, Dilshad E, Suliman, Ashraf NM. Identification of anti-inflammatory metabolites from Trigonella foenum-greacum using computational approaches. Curr Trend Omics. 2022, 2:56-68.","journal-title":"Curr Trend Omics"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.4103\/jpbs.jpbs_518_23","article-title":"Human intelectin-1 (hITL-1) as modulator of metabolic syndrome (MetS): an in silico study","volume":"16","author":"Vishnupriya N","year":"2024","unstructured":"Vishnupriya N, Narayanaswamy R. Human intelectin-1 (hITL-1) as modulator of metabolic syndrome (MetS): an in silico study. J Pharm Bioallied Sci. 2024, 16:S1173-80. 10.4103\/jpbs.jpbs_518_23","journal-title":"J Pharm Bioallied Sci"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1111\/j.1523-1755.2004.00898.x","article-title":"Disease-causing missense mutations in NPHS2 gene alter normal nephrin trafficking to the plasma membrane","volume":"66","author":"Nishibori Y","year":"2004","unstructured":"Nishibori Y, Liu L, Hosoyamada M, et al.. Disease-causing missense mutations in NPHS2 gene alter normal nephrin trafficking to the plasma membrane. Kidney Int. 2004, 66:1755-65. 10.1111\/j.1523-1755.2004.00898.x","journal-title":"Kidney Int"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2014040405","article-title":"Nephrin preserves podocyte viability and glomerular structure and function in adult kidneys","volume":"26","author":"Li X","year":"2015","unstructured":"Li X, Chuang PY, D'Agati VD, et al.. Nephrin preserves podocyte viability and glomerular structure and function in adult kidneys. J Am Soc Nephrol. 2015, 26:2361-77. 10.1681\/ASN.2014040405","journal-title":"J Am Soc Nephrol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00302","article-title":"Nephrin signaling in the podocyte: an updated view of signal regulation at the slit diaphragm and beyond","volume":"9","author":"Martin CE","year":"2018","unstructured":"Martin CE, Jones N. Nephrin signaling in the podocyte: an updated view of signal regulation at the slit diaphragm and beyond. Front Endocrinol (Lausanne). 2018, 9:302. 10.3389\/fendo.2018.00302","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.2337\/db06-0693","article-title":"Nephrin is critical for the action of insulin on human glomerular podocytes","volume":"56","author":"Coward RJ","year":"2007","unstructured":"Coward RJ, Welsh GI, Koziell A, et al.. Nephrin is critical for the action of insulin on human glomerular podocytes. Diabetes. 2007, 56:1127-35. 10.2337\/db06-0693","journal-title":"Diabetes"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1172\/JCI65289","article-title":"Role of dynamin, synaptojanin, and endophilin in podocyte foot processes","volume":"122","author":"Soda K","year":"2012","unstructured":"Soda K, Balkin DM, Ferguson SM, et al.. Role of dynamin, synaptojanin, and endophilin in podocyte foot processes. J Clin Invest. 2012, 122:4401-11. 10.1172\/JCI65289","journal-title":"J Clin Invest"},{"key":"ref30","doi-asserted-by":"crossref","DOI":"10.25303\/1706rjbt67072","article-title":"Protein-protein docking interaction of nephrin protein with the expression of MMP-9: an anti-inflammatory agent","volume":"17","author":"Shree P","year":"2022","unstructured":"Shree P, Srivastava S, Chaube R, Tripathi YB. Protein-protein docking interaction of nephrin protein with the expression of MMP-9: an anti-inflammatory agent. Res J Biotechnol. 2022, 17:67-72.","journal-title":"Res J Biotechnol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/275958-human-and-mouse-nephrin-and-their-interactions-with-13-proteins-an-in-silico-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T02:52:51Z","timestamp":1722999171000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/275958-human-and-mouse-nephrin-and-their-interactions-with-13-proteins-an-in-silico-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,6]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.66332","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8,6]]}}}